Excel Industries Intrinsic Value
EXCELINDUS • Chemicals
Current Stock Price
₹880.45
Primary Intrinsic Value
₹808.80
Market Cap
₹528.3 Cr
+59.0%
Upside
Median Value
₹1400.00
Value Range
₹431 - ₹2201
Assessment
Trading Below Calculated Value
Safety Margin
37.1%
EXCELINDUS Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹808.80 | ₹647.04 - ₹970.56 | -8.1% | EPS: ₹67.40, Sector P/E: 12x |
| Book Value Method | asset | ₹2201.12 | ₹1981.01 - ₹2421.23 | +150.0% | Book Value/Share: ₹2648.33, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹1482.67 | ₹1334.40 - ₹1630.94 | +68.4% | Revenue/Share: ₹1853.33, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹1480.00 | ₹1332.00 - ₹1628.00 | +68.1% | EBITDA: ₹148.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹959.33 | ₹767.46 - ₹1151.20 | +9.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹431.36 | ₹388.22 - ₹474.50 | -51.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹555.38 | ₹499.84 - ₹610.92 | -36.9% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹1400.00 | ₹1260.00 - ₹1540.00 | +59.0% | ROE: 5.3%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹2004.05 | ₹1803.64 - ₹2204.45 | +127.6% | EPS: ₹67.40, BVPS: ₹2648.33 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
EXCELINDUS Intrinsic Value Analysis
What is the intrinsic value of EXCELINDUS?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Excel Industries (EXCELINDUS) is ₹1400.00 (median value). With the current market price of ₹880.45, this represents a +59.0% variance from our estimated fair value.
The valuation range spans from ₹431.36 to ₹2201.12, indicating ₹431.36 - ₹2201.12.
Is EXCELINDUS undervalued or overvalued?
Based on our multi-method analysis, Excel Industries (EXCELINDUS) appears to be trading below calculated value by approximately 59.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 3.51 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 5.3% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 11.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.58x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Excel Industries
Additional stock information and data for EXCELINDUS
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹62 Cr | ₹42 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹72 Cr | ₹47 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹125 Cr | ₹66 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹109 Cr | ₹57 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹91 Cr | ₹65 Cr | Positive Free Cash Flow | 8/10 |